期刊文献+

不同抗真菌药治疗白念珠菌性阴道炎模型小鼠的疗效比较 被引量:1

Comprasion of the Therapeutic Effectiveness of Three Different Anti-fungal Drugs in the Treatment of Vaginitis Caused by Candida Albicans in Mice
下载PDF
导出
摘要 目的比较特比萘芬、氟康唑、伊曲康唑等抗真菌药治疗小鼠白念珠菌性阴道炎的疗效。方法构建ICR小鼠白念珠菌性阴道炎模型,应用特比萘芬、氟康唑、伊曲康唑灌服治疗,并在灌药后不同时间动态观察阴道灌洗液真菌载量。结果特比萘芬组在不同时间点其小鼠阴道灌洗液真菌载量明显高于氟康唑组及伊曲康唑组(P<0.01),连续灌药1周后其真菌载量仍处于较高水平。氟康唑组与伊曲康唑组从灌服药物后第2天开始其阴道灌洗液真菌载量明显减少,灌服药物后第3天开始阴道灌洗液真菌载量即处于极低水平,表明两组疗效显著,但两者之间疗效差异无显著性(P>0.05)。结论特比萘芬治疗小鼠白念珠菌性阴道炎的疗效欠佳,而氟康唑与伊曲康唑治疗小鼠白念珠菌性阴道炎疗效显著。 Objective To compare the therapeutic effectiveness of three different anti-fungal drugs terbindine, fluconazole and itraconazole in the treatment of experimental vaginitis caused by Candida albicans in mice. Methods The fungal vaginitis model was set up in female ICR mice by intravaginal inoculation of suspension of Candida albieans after the animals had been pretreated with estradiol. Mice divided randomly into different groups were then treated with terbinafine, fluconazole and itraconazole, respectively, administered by gastrogavage. The loading of the fungus in the vaginal lavage fluids in mice of the different groups were meatured dynamically at different time points after the beginning of the drug treatment. Results The fungal loadings in the vaginal lavage fluids taken at different time points from mice treated with terbinafine were significantly higher than those taken at corresponding time points from mice treated with fluconazole or itraconazole( P 〈 0.01 ). The fungal loading in the vaginal lavage fluids taken from mice 1 week after the beginning of the treatment with terbinafine remained at a relatively high level, A dramatic fall of the fungal loading in the vaginal lavage fluids taken on the 2nd day of treatment from mice treated with itraconazole or fluconazole group was demonstrated and the fungal loadings on the 3rd day of treatment in these mice were shown to be at a very low level, showing that itraconazole and fluconazole were highly effective in the treatment. However, the difference between the therapeutic effectiveness of these 2 drugs was not significant ( P 〉 0.05 ). Conclusion Itraconazole and fluconazole, but not terbinafine, were shown to be very effective in the treatment of fungal vaginitis caused by Candida albicans in mice.
出处 《医药导报》 CAS 2006年第12期1246-1249,共4页 Herald of Medicine
基金 湖北省卫生厅科研基金资助项目(基金编号:.JXIB048)
关键词 特比萘芬 氟康唑 伊曲康唑 白念珠菌病 阴道 Terbinafine Fluconazole hraconazole Vaginitis, fungal
  • 相关文献

参考文献2

二级参考文献13

  • 1王文莉.念珠菌对唑类药物耐药现象的研究现状[J].国外医学(皮肤性病学分册),1996,22(2):86-89. 被引量:34
  • 2杨冰心.伊曲康唑治疗念珠菌性阴道炎42例.中国皮肤性病学杂志,2001,15:67-67.
  • 3Clayton YM.Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses[].Br J Dermatol.1994
  • 4Faergemann J,Zehender H,Denouel J,Millerioux L.Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks[].Acta Dermato Venereologica.1993
  • 5Faergemann J,Zehender H,Millerioux L.Levels of terbinafine in plasma, stratum corneum, dermis-epidermis ( without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days[].Clinical and Experimental Dermatology.1994
  • 6Schatz F,Bautigam M,Dobrowolski E,et al.Nail incorporation kinetis of terbinafine in onychomycosis patients[].Clinical and Experimental Dermatology.1995
  • 7Finlay AY,Lever L,Thomas R,Dykes PJ.Nail matrix of oral terbinafine in onychomycosis and normal nails[].Journal of Dermatological Treatment.1990
  • 8Jensen JC.Clinical pharmacokinetics of terbinafine[].Clinical and Experimental Dermatology.1989
  • 9Ryder NS,Favre B.Antifungal activity and mechanism of action of terbinafine[].Reviews in Contemporary Pharmacotherapy.1997
  • 10Faergemann J.Pharmacokinetics of terbinafine[].Reviews in Contemporary Pharmacotherapy.1997

共引文献24

同被引文献18

  • 1谭娟,曹菲,丁娟,张少如,吴艳,何甘霖,李家文.不同条件下小鼠白念珠菌性阴道炎易感性的研究[J].华中医学杂志,2005,29(3):149-150. 被引量:1
  • 2Resende J C, de Resende M A, Saliba J L. Prevalence of Can- dida spp. in hospitalized patients and their risk factors[ J]. My- coses, 2002, 45(8) : 306-312.
  • 3Candido R C, Toloi M R, Franceschini S A, et al. In vitro ac- tivity of antimycotic agents determined by E-test method against vaginal Canclida species[J]. Mycopathologia, 1999, 144( 1 ): 15-20.
  • 4Mahmoudi Rad M, Zafarghandi S, Abbasabadi B, et al. The epidemiology of Candida species associated with vulvovaginal candidiasis in an Iranian patient population [ J ]. Eur J Obstet Gynecol Reprod Biol, 2011, 155(2) : 199-203.
  • 5Asticcioli S, Saeco L, Datnri R, et al. Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007 [ J ]. New Microbiol, 2009, 32(2): 199-204.
  • 6Yticesoy M, Marol S. Performance of chromagar Cartdida and biggy agar for identification of yeast species [ J]. Ann Clin Mi- crobiol Antimicrob, 2003, 2 : 8.
  • 7Sendid B, Francois N, Standaert A, et al. Prospective evalua- tion of the new chromogenic medium Candi Select 4 for differen- tiation and presumptive identification of the major pathogenic Candida species[J]. J Med Microbiol, 2007, 56: 495-9.
  • 8Maruyama N, Takizawa T, Ishibashi H, et al. Protective activi- ty of geranium oil and its component, geraniol, in combination with vaginal washing against vaginal candidiasis in mice [ J ]. Biol Pharm Bull, 2008, 31(8) : 1501-1506.
  • 9Lapezynski A, Bhatia S P, Foxenberg R J, et al. Fragrance material review on geraniol [ J ]. Food Chem Toxicol, 2008, 46 (11): S160-170.
  • 10Mendonqa-Ade L, da-Silva C E, de-Mesquita F L, et al. Anti- microbial activities of components of the glandular secretions of leaf cutting ants of the genus Atta [ J ]. Antonie Van Leeuwen- hoek, 2009, 95(4) : 295-303.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部